ClinicalTrials.Veeva

Menu

Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid

L

Lo.Li.Pharma

Status

Enrolling

Conditions

D-chiro-inositol
Epigallocatechin Gallate
Uterine Fibroids
Inositol
Vitamin D
Vitamin B6

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Epigallocatechin gallate, Vitamin D, Vitamin B6, D-chiro-inositol

Study type

Interventional

Funder types

Industry

Identifiers

NCT05448365
DELPHYS PLUS

Details and patient eligibility

About

The study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6.

The patients will be evaluated at baseline and after three months of treatment with placebo or product.

Enrollment

60 estimated patients

Sex

Female

Ages

30 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. uterine fibroid with diameter greater than or equal to 4cm or multiple fibroids
  2. eligible for surgery
  3. symptoms like menometrorrhagia or pelvic pain

Exclusion criteria

  1. BMI>30
  2. currently pregnant or breastfeeding
  3. diabetic
  4. suspect of malignancy
  5. diagnosis of cancer

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups, including a placebo group

EGCG, Vit D, DCI, Vit B6
Active Comparator group
Description:
Women with uterine fibroids randomized to treatment group
Treatment:
Dietary Supplement: Epigallocatechin gallate, Vitamin D, Vitamin B6, D-chiro-inositol
Placebo
Placebo Comparator group
Description:
Women with uterine fibroids randomized to placebo group
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

2

Loading...

Central trial contact

Massimo Stomati, Ph. D; Andrea Tinelli, Ph. D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems